Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8173594rdf:typepubmed:Citationlld:pubmed
pubmed-article:8173594lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:8173594lifeskim:mentionsumls-concept:C1155551lld:lifeskim
pubmed-article:8173594lifeskim:mentionsumls-concept:C0439064lld:lifeskim
pubmed-article:8173594lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:8173594pubmed:issue5lld:pubmed
pubmed-article:8173594pubmed:dateCreated1994-6-6lld:pubmed
pubmed-article:8173594pubmed:abstractTextp42/Mitogen activated protein kinase (MAPK) and MAP Kinase Kinase (MAPKK) activities are constitutively elevated in v-raf transformed NIH3T3 cells, which correlates with increased tyrosine phosphorylation of p42mapk protein. These activities can be further enhanced to a moderate extent by treatment of raf-transformed cells with either serum, tetradecanoyl phorbol acetate (TPA), or aluminium fluoride. A similar activation of MAPK is observed in a cell line (M17raf) coexpressing a dominant inhibitory ras mutant (N-17 ras) along with v-raf. However, in this cell line, both the serum and TPA stimulated response of MAPK activity is reduced compared to similarly treated raf-transformed cells, while aluminium fluoride is equally potent in all the cell lines tested. These studies indicate that in addition to c-Raf-1, serine/threonine kinase, which is an upstream activator of MAPK, other c-ras dependent as well as c-ras independent pathways also can contribute to MAPK activation.lld:pubmed
pubmed-article:8173594pubmed:languageenglld:pubmed
pubmed-article:8173594pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8173594pubmed:citationSubsetIMlld:pubmed
pubmed-article:8173594pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8173594pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8173594pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8173594pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8173594pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8173594pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8173594pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8173594pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8173594pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8173594pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8173594pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8173594pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8173594pubmed:statusMEDLINElld:pubmed
pubmed-article:8173594pubmed:issn0968-8773lld:pubmed
pubmed-article:8173594pubmed:authorpubmed-author:MitraGGlld:pubmed
pubmed-article:8173594pubmed:authorpubmed-author:WeberMMlld:pubmed
pubmed-article:8173594pubmed:authorpubmed-author:StaceyDDlld:pubmed
pubmed-article:8173594pubmed:issnTypePrintlld:pubmed
pubmed-article:8173594pubmed:volume39lld:pubmed
pubmed-article:8173594pubmed:ownerNLMlld:pubmed
pubmed-article:8173594pubmed:authorsCompleteYlld:pubmed
pubmed-article:8173594pubmed:pagination517-23lld:pubmed
pubmed-article:8173594pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:8173594pubmed:meshHeadingpubmed-meshheading:8173594-...lld:pubmed
pubmed-article:8173594pubmed:meshHeadingpubmed-meshheading:8173594-...lld:pubmed
pubmed-article:8173594pubmed:meshHeadingpubmed-meshheading:8173594-...lld:pubmed
pubmed-article:8173594pubmed:meshHeadingpubmed-meshheading:8173594-...lld:pubmed
pubmed-article:8173594pubmed:meshHeadingpubmed-meshheading:8173594-...lld:pubmed
pubmed-article:8173594pubmed:meshHeadingpubmed-meshheading:8173594-...lld:pubmed
pubmed-article:8173594pubmed:meshHeadingpubmed-meshheading:8173594-...lld:pubmed
pubmed-article:8173594pubmed:meshHeadingpubmed-meshheading:8173594-...lld:pubmed
pubmed-article:8173594pubmed:meshHeadingpubmed-meshheading:8173594-...lld:pubmed
pubmed-article:8173594pubmed:meshHeadingpubmed-meshheading:8173594-...lld:pubmed
pubmed-article:8173594pubmed:meshHeadingpubmed-meshheading:8173594-...lld:pubmed
pubmed-article:8173594pubmed:meshHeadingpubmed-meshheading:8173594-...lld:pubmed
pubmed-article:8173594pubmed:meshHeadingpubmed-meshheading:8173594-...lld:pubmed
pubmed-article:8173594pubmed:meshHeadingpubmed-meshheading:8173594-...lld:pubmed
pubmed-article:8173594pubmed:meshHeadingpubmed-meshheading:8173594-...lld:pubmed
pubmed-article:8173594pubmed:meshHeadingpubmed-meshheading:8173594-...lld:pubmed
pubmed-article:8173594pubmed:meshHeadingpubmed-meshheading:8173594-...lld:pubmed
pubmed-article:8173594pubmed:meshHeadingpubmed-meshheading:8173594-...lld:pubmed
pubmed-article:8173594pubmed:year1993lld:pubmed
pubmed-article:8173594pubmed:articleTitleMultiple pathways for activation of MAP kinases.lld:pubmed
pubmed-article:8173594pubmed:affiliationDepartment of Molecular Biology, Cleveland Clinic Foundation, OH.lld:pubmed
pubmed-article:8173594pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8173594lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8173594lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8173594lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8173594lld:pubmed